Postoperative Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

Description

Market Players Eyeing Growth Opportunities in Asia and MEA as Opioid Concerns Rise

The global market for postoperative pain management is poised for significant growth, with a valuation of US$ 37 billion in 2024 and a projected Compound Annual Growth Rate (CAGR) of 7% to reach US$ 57.8 billion by 2031.

Rising Demand for Pain Management Drugs

One of the key drivers of market growth is the increasing prevalence of chronic diseases and a growing number of surgical procedures worldwide. The National Health statistics report that the U.S. alone witnesses 100 million surgeries annually, contributing significantly to the consumption of pain management drugs. Additionally, the rising incidence of cancer therapy-associated pain and an aging population undergoing various surgeries are fueling market expansion.

Impact of Road Accidents on Market Growth

The market is also expected to benefit from the increasing number of road accidents globally. Trauma injuries resulting from accidents often lead to high levels of pain, making postoperative pain management essential. Key players are ramping up their production to meet the demand arising from these incidents, contributing positively to market growth.

Focus on Abuse-Deterrent Opioids and Non-Opioid Drugs

Furthermore, the market is witnessing a surge in demand for painkiller drugs due to an increasing focus on the development of abuse-deterrent opioid drugs and extended-release non-opioid drugs for post-surgery pain management. Increased awareness of post-surgery pain control, coupled with the development and commercialization of non-narcotic drugs and non-abuse opioids, is supplementing market growth.

Opportunities in Asia and MEA

While opioids remain commonly used for postoperative pain management in North America and Europe, concerns about their non-medical use have led governing bodies to encourage the prescription of non-opioid drugs. This shift presents opportunities for companies to introduce novel non-opioid drugs in these regions. In contrast, Asia and Africa face a lack of efficient postoperative pain management medications, creating potential growth opportunities for market players.

Challenges to Market Expansion

However, market growth faces challenges, including growing concerns about the opioid epidemic and the increasing cost burden of pain management on reimbursement providers. Adverse side effects associated with excessive intake of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and opioids, as well as limited availability of postoperative pain management drugs in certain regions, are hindering market growth.

Country-Wise Insights

U.S. - A Strong Market: The U.S. is a significant market for postoperative pain management, primarily due to its robust pipeline of postoperative pain management drugs and efforts to combat the opioid epidemic. The adoption of opioid management treatments is expected to reduce opioid-related issues. Additionally, the U.S. has a strong drug pipeline, with new and effective drugs seeking approval from the U.S. Food and Drug Administration, further driving the use of postoperative pain management drugs.
Germany - Leading in Europe: Germany is a lucrative market for postoperative pain management in Europe. This is attributed to the high incidence and severity of postoperative pain in the country, the introduction of promising drugs, an increasing number of surgical procedures, and a high rate of pain management procedures. The acceptance of Opioid Maintenance Treatment (OMT) for opioid dependence in Germany is also a significant factor boosting the demand for postoperative pain management drugs.
China - Rapid Growth: In China, the demand for postoperative pain management medication is being fueled by a high number of surgeries being performed in the country. Numerous pain management drug manufacturers are engaging in distribution agreements, partnerships, and launching postoperative pain management medications, particularly in the Asia Pacific region, with China at the forefront of this growth.

Competitive Analysis

Leading suppliers of postoperative pain management medicines are focusing on collaborations and acquisitions with pharmaceutical companies to develop novel product lines for pain management.

Key Companies Profiled:

Teva Pharmaceutical Industries Ltd.
Novartis AG
Allergan plc
Mylan N.V.
Pfizer Inc.
Purdue Pharma L.P.
Janssen Pharmaceuticals, Inc.
Endo International plc.
Pacira Pharmaceuticals Inc.
Egalet Corporation
GlaxoSmithKline Plc.

Postoperative Pain Management Industry Survey by Category

Postoperative Pain Management Market by Drug Class:

Opioids
NSAIDs
Local Anesthetic
Acetaminophen

Postoperative Pain Management Market by Route of Administration:

Injectable Postoperative Pain Management
Oral Postoperative Pain Management
Topical Postoperative Pain Management
Transdermal Postoperative Pain Management
Others

Postoperative Pain Management Market by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Clinics
Others

Postoperative Pain Management Market by Region:

North America Postoperative Pain Management Market
Latin America Postoperative Pain Management Market
Europe Postoperative Pain Management Market
East Asia Postoperative Pain Management Market
South Asia Postoperative Pain Management Market
Oceania Postoperative Pain Management Market
The Middle East and Africa (MEA) Postoperative Pain Management Market

1. Executive Summary

1.1. Global Postoperative Pain Management Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Postoperative Pain Management Market Outlook, 2018 - 2031

3.1. Global Postoperative Pain Management Market Outlook, by Drug Class, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Opioids
  - 3.1.1.2. NSAIDs
  - 3.1.1.3. Local Anesthetic
  - 3.1.1.4. Acetaminophen
3.2. Global Postoperative Pain Management Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Injectable Postoperative Pain Management
  - 3.2.1.2. Oral Postoperative Pain Management
  - 3.2.1.3. Topical Postoperative Pain Management
  - 3.2.1.4. Transdermal Postoperative Pain Management
  - 3.2.1.5. Others
3.3. Global Postoperative Pain Management Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Hospital Pharmacies
  - 3.3.1.2. Retail Pharmacies
  - 3.3.1.3. Drug Stores
  - 3.3.1.4. Clinics
  - 3.3.1.5. Others
3.4. Global Postoperative Pain Management Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. North America
  - 3.4.1.2. Europe
  - 3.4.1.3. Asia Pacific
  - 3.4.1.4. Latin America
  - 3.4.1.5. Middle East & Africa

4. North America Postoperative Pain Management Market Outlook, 2018 - 2031

4.1. North America Postoperative Pain Management Market Outlook, by Drug Class, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Opioids
  - 4.1.1.2. NSAIDs
  - 4.1.1.3. Local Anesthetic
  - 4.1.1.4. Acetaminophen
4.2. North America Postoperative Pain Management Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Injectable Postoperative Pain Management
  - 4.2.1.2. Oral Postoperative Pain Management
  - 4.2.1.3. Topical Postoperative Pain Management
  - 4.2.1.4. Transdermal Postoperative Pain Management
  - 4.2.1.5. Others
4.3. North America Postoperative Pain Management Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Hospital Pharmacies
  - 4.3.1.2. Retail Pharmacies
  - 4.3.1.3. Drug Stores
  - 4.3.1.4. Clinics
  - 4.3.1.5. Others
- 4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Postoperative Pain Management Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. U.S. Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 4.4.1.2. U.S. Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 4.4.1.3. U.S. Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 4.4.1.4. Canada Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 4.4.1.5. Canada Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 4.4.1.6. Canada Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Postoperative Pain Management Market Outlook, 2018 - 2031

5.1. Europe Postoperative Pain Management Market Outlook, by Drug Class, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Opioids
  - 5.1.1.2. NSAIDs
  - 5.1.1.3. Local Anesthetic
  - 5.1.1.4. Acetaminophen
5.2. Europe Postoperative Pain Management Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Injectable Postoperative Pain Management
  - 5.2.1.2. Oral Postoperative Pain Management
  - 5.2.1.3. Topical Postoperative Pain Management
  - 5.2.1.4. Transdermal Postoperative Pain Management
  - 5.2.1.5. Others
5.3. Europe Postoperative Pain Management Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Hospital Pharmacies
  - 5.3.1.2. Retail Pharmacies
  - 5.3.1.3. Drug Stores
  - 5.3.1.4. Clinics
  - 5.3.1.5. Others
- 5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Postoperative Pain Management Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Germany Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 5.4.1.2. Germany Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 5.4.1.3. Germany Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 5.4.1.4. U.K. Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 5.4.1.5. U.K. Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 5.4.1.6. U.K. Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 5.4.1.7. France Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 5.4.1.8. France Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 5.4.1.9. France Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 5.4.1.10. Italy Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 5.4.1.11. Italy Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 5.4.1.12. Italy Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 5.4.1.13. Turkey Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 5.4.1.14. Turkey Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 5.4.1.15. Turkey Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 5.4.1.16. Russia Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 5.4.1.17. Russia Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 5.4.1.18. Russia Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 5.4.1.19. Rest of Europe Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 5.4.1.20. Rest of Europe Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 5.4.1.21. Rest of Europe Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Postoperative Pain Management Market Outlook, 2018 - 2031

6.1. Asia Pacific Postoperative Pain Management Market Outlook, by Drug Class, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Opioids
  - 6.1.1.2. NSAIDs
  - 6.1.1.3. Local Anesthetic
  - 6.1.1.4. Acetaminophen
6.2. Asia Pacific Postoperative Pain Management Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Injectable Postoperative Pain Management
  - 6.2.1.2. Oral Postoperative Pain Management
  - 6.2.1.3. Topical Postoperative Pain Management
  - 6.2.1.4. Transdermal Postoperative Pain Management
  - 6.2.1.5. Others
6.3. Asia Pacific Postoperative Pain Management Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Hospital Pharmacies
  - 6.3.1.2. Retail Pharmacies
  - 6.3.1.3. Drug Stores
  - 6.3.1.4. Clinics
  - 6.3.1.5. Others
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Postoperative Pain Management Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. China Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 6.4.1.2. China Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 6.4.1.3. China Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 6.4.1.4. Japan Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 6.4.1.5. Japan Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 6.4.1.6. Japan Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 6.4.1.7. South Korea Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 6.4.1.8. South Korea Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 6.4.1.9. South Korea Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 6.4.1.10. India Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 6.4.1.11. India Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 6.4.1.12. India Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 6.4.1.13. Southeast Asia Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 6.4.1.14. Southeast Asia Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 6.4.1.15. Southeast Asia Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 6.4.1.16. Rest of Asia Pacific Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 6.4.1.17. Rest of Asia Pacific Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 6.4.1.18. Rest of Asia Pacific Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Postoperative Pain Management Market Outlook, 2018 - 2031

7.1. Latin America Postoperative Pain Management Market Outlook, by Drug Class, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Opioids
  - 7.1.1.2. NSAIDs
  - 7.1.1.3. Local Anesthetic
  - 7.1.1.4. Acetaminophen
7.2. Latin America Postoperative Pain Management Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Injectable Postoperative Pain Management
  - 7.2.1.2. Oral Postoperative Pain Management
  - 7.2.1.3. Topical Postoperative Pain Management
  - 7.2.1.4. Transdermal Postoperative Pain Management
  - 7.2.1.5. Others
7.3. Latin America Postoperative Pain Management Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Hospital Pharmacies
  - 7.3.1.2. Retail Pharmacies
  - 7.3.1.3. Drug Stores
  - 7.3.1.4. Clinics
  - 7.3.1.5. Others
- 7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Postoperative Pain Management Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Brazil Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 7.4.1.2. Brazil Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 7.4.1.3. Brazil Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 7.4.1.4. Mexico Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 7.4.1.5. Mexico Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 7.4.1.6. Mexico Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 7.4.1.7. Argentina Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 7.4.1.8. Argentina Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 7.4.1.9. Argentina Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 7.4.1.10. Rest of Latin America Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 7.4.1.11. Rest of Latin America Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 7.4.1.12. Rest of Latin America Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Postoperative Pain Management Market Outlook, 2018 - 2031

8.1. Middle East & Africa Postoperative Pain Management Market Outlook, by Drug Class, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Opioids
  - 8.1.1.2. NSAIDs
  - 8.1.1.3. Local Anesthetic
  - 8.1.1.4. Acetaminophen
8.2. Middle East & Africa Postoperative Pain Management Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Injectable Postoperative Pain Management
  - 8.2.1.2. Oral Postoperative Pain Management
  - 8.2.1.3. Topical Postoperative Pain Management
  - 8.2.1.4. Transdermal Postoperative Pain Management
  - 8.2.1.5. Others
8.3. Middle East & Africa Postoperative Pain Management Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Hospital Pharmacies
  - 8.3.1.2. Retail Pharmacies
  - 8.3.1.3. Drug Stores
  - 8.3.1.4. Clinics
  - 8.3.1.5. Others
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Postoperative Pain Management Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. GCC Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 8.4.1.2. GCC Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 8.4.1.3. GCC Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 8.4.1.4. South Africa Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 8.4.1.5. South Africa Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 8.4.1.6. South Africa Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 8.4.1.7. Egypt Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 8.4.1.8. Egypt Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 8.4.1.9. Egypt Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 8.4.1.10. Nigeria Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 8.4.1.11. Nigeria Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 8.4.1.12. Nigeria Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 8.4.1.13. Rest of Middle East & Africa Postoperative Pain Management Market by Drug Class, Value (US$ Bn), 2018 - 2031
  - 8.4.1.14. Rest of Middle East & Africa Postoperative Pain Management Market by Route of Administration, Value (US$ Bn), 2018 - 2031
  - 8.4.1.15. Rest of Middle East & Africa Postoperative Pain Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Drug Class vs Route of Administration Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Teva Pharmaceutical Industries Ltd.
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. Novartis AG
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. Allergan plc
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. Mylan N.V.
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. Pfizer Inc.
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. Purdue Pharma L.P
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. Janssen Pharmaceuticals, Inc.
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. Endo International plc.
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Development
- 9.4.9. Pacira Pharmaceuticals Inc.
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development
- 9.4.10. Egalet Corporation
  - 9.4.10.1. Company Overview
  - 9.4.10.2. Product Portfolio
  - 9.4.10.3. Financial Overview
  - 9.4.10.4. Business Strategies and Development
- 9.4.11. GlaxoSmithKline Plc.
  - 9.4.11.1. Company Overview
  - 9.4.11.2. Product Portfolio
  - 9.4.11.3. Financial Overview
  - 9.4.11.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations